Literature DB >> 18196595

Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics.

Ali Balci1, Sinem Karazincir, Haldun Sumbas, Yasemin Oter, Ertugrul Egilmez, Tacettin Inandi.   

Abstract

PURPOSE: To investigate the effects of various degrees of diffuse fatty infiltration of the liver on portal vein blood flow with Doppler sonography.
METHODS: One hundred forty subjects were examined with color and spectral Doppler sonography. The subjects were divided into 4 groups of 35 subjects each according to the degree (normal, grade 1, grade 2 and grade 3) of hepatic fatty infiltration assessed on gray-scale images. The portal vein pulsatility index (VPI) and time-averaged mean flow velocity (MFV) were calculated for each subject. VPI was calculated as (peak maximum velocity - peak minimum velocity) / peak maximum velocity.
RESULTS: VPI and MFV values were, respectively, 0.32 +/- 0.06 and 16.8 +/- 2.6 cm/second in the normal group, 0.27 +/- 0.07 and 14.2 +/- 2.2 cm/second in the group with grade 1 fatty infiltration, 0.22 +/- 0.06 and 12.2 +/- 1.8 cm/second in the group with grade 2 fatty infiltration, and 0.18 +/- 0.04 and 10.8 +/- 1.5 cm/second in the group with grade 3 fatty infiltration. There was a negative inverse correlation between the grade of fatty infiltration and both VPI (f = 55.3, p < 0.001) and MFV (f = 43.9, p < 0.001).
CONCLUSION: The pulsatility index and mean velocity of the portal vein blood flow decrease as the severity of fatty infiltration increases. (Copyright) 2007 Wiley Periodicals, Inc.

Mesh:

Year:  2008        PMID: 18196595     DOI: 10.1002/jcu.20440

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  18 in total

Review 1.  Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.

Authors:  Gyorgy Baffy
Journal:  Dig Dis Sci       Date:  2018-01-22       Impact factor: 3.199

2.  Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.

Authors:  Masoud Baikpour; Arinc Ozturk; Manish Dhyani; Nathaniel D Mercaldo; Theodore T Pierce; Joseph R Grajo; Anthony E Samir
Journal:  AJR Am J Roentgenol       Date:  2020-01-15       Impact factor: 3.959

3.  Evaluation of liver perfusion in diabetic patients using 99mTc-sestamibi.

Authors:  Hacer Şen; Yusuf Ziya Tan; Emine Binnetoğlu; Mehmet Aşik; Fahri Güneş; Gökhan Erbağ; Emine Gazi; Sibel Cevizci; Semra Özdemir; Erdem Akbal; Kubilay Ükinç
Journal:  Wien Klin Wochenschr       Date:  2014-09-19       Impact factor: 1.704

4.  Evaluation of portal venous velocity with Doppler ultrasound in patients with nonalcoholic fatty liver disease.

Authors:  Serife Ulusan; Tolga Yakar; Zafer Koc
Journal:  Korean J Radiol       Date:  2011-07-22       Impact factor: 3.500

5.  Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.

Authors:  Georgi Kirovski; Doris Schacherer; Hella Wobser; Hanna Huber; Christoph Niessen; Catrin Beer; Jürgen Schölmerich; Claus Hellerbrand
Journal:  Int J Clin Exp Med       Date:  2010-07-15

6.  Diffusion analysis with triexponential function in hepatic steatosis.

Authors:  Tatsuya Hayashi; Tosiaki Miyati; Junji Takahashi; Yoshinori Tsuji; Hidesato Suzuki; Naomi Tagaya; Mariko Hiramoto; Kei Fukuzawa; Masakatsu Tano; Satoshi Saitoh
Journal:  Radiol Phys Technol       Date:  2013-10-04

7.  Assessment of Portal Venous and Hepatic Artery Haemodynamic Variation in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients.

Authors:  Padhmini Balasubramanian; Vinoth Boopathy; Ezhumalai Govindasamy; Basavaiya Prabhu Venkatesh
Journal:  J Clin Diagn Res       Date:  2016-08-01

8.  Dexmedetomidine pharmacokinetics in the obese.

Authors:  Luis I Cortínez; Brian J Anderson; Nick H G Holford; Valentina Puga; Natalia de la Fuente; Hernán Auad; Sandra Solari; Fidel A Allende; Mauricio Ibacache
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

9.  Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard.

Authors:  Dae Yoon Kim; Seong Ho Park; Seung Soo Lee; Hye Jin Kim; So Yeon Kim; Min-Young Kim; Yedaun Lee; Tae Kyoung Kim; Korosh Khalili; Mi Hyun Bae; Joo Yeon Lee; Sung-Gyu Lee; Eun Sil Yu
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

10.  Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.

Authors:  Luuk J Rijzewijk; Rutger W van der Meer; Mark Lubberink; Hildo J Lamb; Johannes A Romijn; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  Diabetes       Date:  2010-08-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.